Thyrotoxicosis and giant-cell arteritis.
In a retrospective survey we found that five (8.5%) out of 59 women with giant-cell arteritis had a history of thyrotoxicosis. This was significantly higher than in a control group of patients. Giant-cell arteritis and thyrotoxicosis occurred simultaneously in two cases. Knowledge of this association is of clinical use and is further evidence for an immunological basis for giant-cell arteritis.
D000368:Aged; D001327:Autoimmune Diseases / Q000175:diagnosis; D001706:Biopsy; D005260:Female; D013700:Giant Cell Arteritis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D006400:Hematocrit; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D007037:Hypothyroidism / Q000209:etiology* / Q000276:immunology; D007457:Iodine Radioisotopes; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D013963:Thyroid Hormones / Q000097:blood
D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D011241:Prednisone